Yep, that's the big play. Astra Zeneca didn't have the expertise to run the trials. Prof. Sinclair is the world expert and in the stock head podcast, her team had run 4 of the 5 RCTs in IIH.
If the drug is registered, then Astra could possibly be a suitor, especially if the production of peptides come easily to them.
- Forums
- ASX - By Stock
- IXC
- Ann: Investor Presentation
Ann: Investor Presentation, page-7
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.763M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 9.0¢ | $575 | 6.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 84879 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 6250 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 84879 | 0.076 |
1 | 5000 | 0.075 |
1 | 500000 | 0.040 |
1 | 70001 | 0.036 |
1 | 100001 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 6250 | 2 |
0.150 | 713 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 12.56pm 04/11/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |